Cargando…
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
The SARS-CoV-2 pandemic that causes COVID-19 respiratory syndrome has caused global public health and economic crises, necessitating rapid development of vaccines and therapeutic countermeasures. The world-wide response to the COVID-19 pandemic has been unprecedented with government, academic, and p...
Autores principales: | Sempowski, Gregory D., Saunders, Kevin O., Acharya, Priyamvada, Wiehe, Kevin J., Haynes, Barton F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250787/ https://www.ncbi.nlm.nih.gov/pubmed/32492407 http://dx.doi.org/10.1016/j.cell.2020.05.041 |
Ejemplares similares
-
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023) -
Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness
por: Pogostin, Brett H., et al.
Publicado: (2021) -
Vaccines and Antiviral Drugs in Pandemic Preparedness
por: Monto, Arnold S.
Publicado: (2006) -
Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021) -
Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage
por: Henderson, Rory, et al.
Publicado: (2023)